|
Chemicals
for Biopharmaceutical Processes
The
Biopharmaceutical industry uses Doe &
Ingall's products and services to help support
their basic research, analytical and full-scale
manufacturing processes. Doe & Ingalls
supplies high quality raw materials used during
upstream, downstream and final packaging phases.
The core products
we supply include:
- Media
- cGMP Buffer Salts and Solutions
- Nutrients
- Disinfectants
- Cleaning Solutions
These products
assist in:
- Fermentation and Cell Culture Applications
- Purification of Targeted Proteins
- Final Fill & Formulation
The complexity,
costs and risks of developing a new drug have
skyrocketed. Biopharmaceutical manufacturers can
trust Doe & Ingalls to provide them with the
uninterrupted supply of raw materials that meet
all of their regulatory requirements.
It is
estimated that the average cost of
developing a prescription drug is over $800 million dollars.
This figure includes the costs of
failures as well as the opportunity cost
of funds spent on R&D that could
have been earning money in another
investment.
Source: The Tufts Center for the Study
of Drug Development, 2000
|
Doe &
Ingalls has built our business with the
objective of helping our customers lower these
costs. We represent products from premier
suppliers who consistently meet the necessary
purity, service and regulatory requirements you
demand.
Our value-added
services include:
- JIT (Just In Time) Deliveries
- cGMP Compliant Facilities
- Technical Knowledge of the
Biopharmaceutical Industry
- Extensive Sourcing Capabilities
- A Strong Commitment to be a True Partner
with Our Customers.
We invite you to
audit any of our four strategically located
facilities in North Carolina , Florida ,
Virginia or Massachusetts . Give us a call and
see what Doe & Ingalls can do for you.
To see the Doe
& Ingalls Biopharmaceutical Chemicals
products, please click
here.
|
